Tirbanibulin
Tirbanibulin, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Phase 2.
| Trivial name | KX 01 |
| Catalog Number | S2700 |
| Molecular Formula | C26H29N3O3 |
| CAS# | 897016-82-9 |
| Inchi | InChI=1S/C26H29N3O3/c30-26(28-19-21-4-2-1-3-5-21)18-24-9-6-23(20-27-24)22-7-10-25(11-8-22)32-17-14-29-12-15-31-16-13-29/h1-11,20H,12-19H2,(H,28,30) |
| Inchi Key | HUNGUWOZPQBXGX-UHFFFAOYSA-N |
| SMILES | C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4 |
| Size | 50mg |
| Supplier Page | http://www.selleckchem.com/products/kx2-391.html |
| Additional Information | https://file.selleck.cn/downloads/struct/KX2-391-chemical-structure-s2700.gif |